Patient Guide: A Prospective Real World Evidence Study (PROWES) for Concordance Rate of Blood-based 3D Genome Conformation Mapping (Episwitch CiRT®) to Identify Likelihood of Response and Actual Response Rates to PD-(L)-1 Checkpoint Inhibitors Across Multiple Oncological Indications.

We'll Help You Connect with This Trial

Quri.ai is a free clinical trial matching service. We help patients like you connect directly with research sites conducting this study.

✓ Get matched to the right study location for you
✓ Connect directly with study coordinators at 3 participating sites
✓ Understand eligibility with our simplified screening tool
✓ Free service - we're here to help you access clinical research

Trial ID: NCTNCT06635954

Status: 🟢 Enrolling Now

Condition: Cancer, Immunotherapy, PD-1, PD-L1, Immune Checkpoint Therapy

Phase: Research Study

Find a Study Location Near You

This study is available at 3 research sites. We'll help you connect with the location that's right for you.

Participating sites include:

• Norwich, Connecticut
• Dublin, Georgia
• Rock Hill, South Carolina

Loading interactive enrollment tools...

The full interactive experience will load momentarily

A Prospective Real World Evidence Study (PROWES) for Concordance Rate of Blood-based 3D Genome Conformation Mapping (Episwitch CiRT®) to Identify Likelihood of Response and Actual Response Rates to PD-(L)-1 Checkpoint Inhibitors Across Multiple Oncological Indications. - Join Clinical Trial NCTNCT06635954

How to Join This Clinical Trial - NCTNCT06635954

Learn how to participate in this clinical trial studying an investigational therapy for Cancer, Immunotherapy, PD-1, PD-L1, Immune Checkpoint Therapy. This study is currently enrolling participants.

Am I Eligible for This Clinical Trial?

This clinical research study is looking for participants with Cancer, Immunotherapy, PD-1, PD-L1, Immune Checkpoint Therapy. Eligibility requirements include specific age ranges, health status, and medical history. Contact the study team to learn if you qualify.

Condition Being Studied: Cancer, Immunotherapy, PD-1, PD-L1, Immune Checkpoint Therapy
Treatment Being Tested: Investigational treatment
Study Phase: Clinical trial phase - Research study
Enrollment Status: Currently enrolling participants
Study Identifier: NCTNCT06635954 - ClinicalTrials.gov Identifier
Sponsored By: Study sponsor

What to Expect as a Participant

Participating in this clinical trial involves:

Initial screening to determine eligibility
Regular study visits and health assessments
Receiving the study treatment or placebo
Medical monitoring and follow-up care
Contributing to medical research that may help others
Potential access to new treatments before they're widely available

Clinical Trial Benefits and Compensation

Participants in this clinical research study may receive:

Close medical monitoring by healthcare professionals
Access to potential new treatments
Compensation for time and travel (varies by study)
No-cost study-related medical care
The opportunity to help advance medical knowledge

Where Is This Clinical Trial Located?

This study is enrolling participants at 3 locations. Find a study site near you:

Clinical Research Site

Norwich, Connecticut 06360 - United States

Status: RECRUITING

Clinical Research Site

Dublin, Georgia 31021 - United States

Status: RECRUITING

Clinical Research Site

Rock Hill, South Carolina 29732 - United States

Status: RECRUITING

How to Enroll in This Study

To learn more about participating in this clinical trial for Cancer, Immunotherapy, PD-1, PD-L1, Immune Checkpoint Therapy:

Review the eligibility criteria with your healthcare provider
Contact the study team for a pre-screening interview
Schedule an in-person screening visit if eligible
Review and sign the informed consent form
Begin participation in the clinical trial

Why Choose Quri.ai as Your Clinical Trial Matching Service

Quri.ai is a free clinical trial matching service that helps patients connect with research sites. We make it easier to:

Find clinical trials that match your condition
Get matched to the right study location near you
Connect directly with study coordinators
Understand if you qualify with simplified eligibility screening
Navigate the enrollment process with personalized support
Access new treatments through clinical research participation